• 1. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782
• 2. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 3. Emergence of microfluidic wearable technologies
  Joo Chuan Yeo,Kenry Lab Chip, 2016,16, 4082-4090
• 4. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 5. Dissociative dynamics of O2 on Ag(110)?
  Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445

Ethyl 4-Methyl-2-Oxo-3,6-Dihydro-1H-Pyrimidine-5-Carboxylate: A Comprehensive Overview

Ethyl 4-methyl-2-oxo-3,6-dihydro-1H-pyrimidine-5-carboxylate, also known by its CAS number 17994-55-7, is a compound of significant interest in the fields of organic chemistry and pharmacology. This compound belongs to the class of pyrimidine derivatives, which are widely studied for their potential applications in drug discovery and material science. The pyrimidine ring system is a heterocyclic aromatic compound with two nitrogen atoms at positions 1 and 3, making it a versatile scaffold for various chemical modifications.

The structure of ethyl 4-methyl-2-oxo-3,6-dihydro-1H-pyrimidine-5-carboxylate features a pyrimidine core with substituents that include a methyl group at position 4, an oxo group at position 2, and an ethyl ester group at position 5. These substituents contribute to the compound's unique chemical properties and reactivity. Recent studies have highlighted the importance of such modifications in enhancing the bioavailability and pharmacokinetic profiles of pyrimidine-based drugs.

One of the most notable applications of this compound is in the development of antiviral agents. Researchers have explored its potential as a component in antiviral therapies due to its ability to inhibit viral replication mechanisms. For instance, studies have shown that ethyl 4-methyl-2-oxo derivatives can interfere with viral RNA polymerase activity, making them promising candidates for treating infections caused by RNA viruses such as influenza and coronaviruses.

In addition to its antiviral properties, ethyl 4-methyl-2-oxo derivatives have also been investigated for their antitumor activity. Preclinical studies suggest that these compounds can induce apoptosis in cancer cells by targeting specific signaling pathways. This makes them a potential lead for developing novel anticancer drugs with reduced side effects compared to traditional chemotherapy agents.

The synthesis of ethyl 4-methyl-2-oxy derivatives has been optimized through various methodologies, including microwave-assisted synthesis and catalytic cross-coupling reactions. These advancements have not only improved the yield but also reduced the environmental footprint of the production process. For example, recent research has demonstrated the use of eco-friendly solvents and catalysts to synthesize this compound on an industrial scale.

From an analytical standpoint, ethyl 4-methyl derivatives are often characterized using advanced spectroscopic techniques such as NMR spectroscopy and mass spectrometry. These methods provide detailed insights into the compound's molecular structure and purity, ensuring its quality for pharmaceutical applications.

Looking ahead, the development of ethyl 4-methyl derivatives is expected to continue gaining momentum as researchers explore new avenues for their application. Collaborative efforts between academia and industry are likely to accelerate the translation of these compounds into clinical settings.

• 349650-89-1(5-Pyrimidinecarboxylicacid, 4-hexyl-1,2,3,4-tetrahydro-6-methyl-2-oxo-, methyl ester)
• 333439-11-5(4,6-Dimethyl-2-oxo-1,2,3,4-tetrahydro-pyrimidine-5-carboxylic acid isopropyl ester)
• 341011-20-9(5-Pyrimidinecarboxylicacid, 1,2,3,4-tetrahydro-4,6-dimethyl-2-oxo-, methyl ester)
• 813453-74-6(5-Pyrimidinecarboxylicacid, 1,2,3,6-tetrahydro-4-methyl-2-thioxo-, 2-propen-1-yl ester)
• 159582-41-9(5-Pyrimidinecarboxylicacid, 1,2,3,6-tetrahydro-4-methyl-2-thioxo-, ethyl ester)
• 14903-94-7(ethyl 6-(bromomethyl)-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate)
• 33458-27-4(Ethyl 2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate)
• 28485-17-8(ethyl 2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate)
• 51622-67-4(6-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylic acid)
• 744202-87-7(5-Pyrimidinecarboxylicacid,6-ethyl-1,2,3,6-tetrahydro-1,4-dimethyl-2-oxo-,ethylester(9CI))